ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal
Los Angeles, CA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Los Angeles. – February 2, 2023 – Today, ANEUVO, a platform and
Globe Newswire2-02-2023, 22:36
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab) 5-04-2024, 12:00